These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2270484)

  • 1. Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome.
    Mayeno AN; Lin F; Foote CS; Loegering DA; Ames MM; Hedberg CW; Gleich GJ
    Science; 1990 Dec; 250(4988):1707-8. PubMed ID: 2270484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of substances formed by decomposition of peak E substance in tryptophan.
    Ito J; Hosaki Y; Torigoe Y; Sakimoto K
    Food Chem Toxicol; 1992 Jan; 30(1):71-81. PubMed ID: 1544609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update: analysis of L-tryptophan for the etiology of eosinophilia-myalgia syndrome.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1990 Nov; 39(43):789-90. PubMed ID: 2122210
    [No Abstract]   [Full Text] [Related]  

  • 4. From the Centers for Disease Control. Analysis of L-tryptophan for etiology of eosinophilia-myalgia syndrome.
    JAMA; 1990 Nov; 264(20):2620. PubMed ID: 2232033
    [No Abstract]   [Full Text] [Related]  

  • 5. A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan).
    Silver RM; Ludwicka A; Hampton M; Ohba T; Bingel SA; Smith T; Harley RA; Maize J; Heyes MP
    J Clin Invest; 1994 Apr; 93(4):1473-80. PubMed ID: 8163652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of contaminants in EMS-associated L-tryptophan samples by high-performance liquid chromatography.
    Toyo'oka T; Yamazaki T; Tanimoto T; Sato K; Sato M; Toyoda M; Ishibashi M; Yoshihira K; Uchiyama M
    Chem Pharm Bull (Tokyo); 1991 Mar; 39(3):820-2. PubMed ID: 2070471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure determination of disease associated peak AAA from l-Tryptophan implicated in the eosinophilia-myalgia syndrome.
    Klarskov K; Gagnon H; Boudreault PL; Normandin C; Plancq B; Marsault E; Gleich GJ; Naylor S
    Toxicol Lett; 2018 Jan; 282():71-80. PubMed ID: 29037509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peak AAA fatty acid homolog contaminants present in the dietary supplement l-Tryptophan associated with the onset of eosinophilia-myalgia syndrome.
    Klarskov K; Gagnon H; Racine M; Boudreault PL; Normandin C; Marsault E; Gleich GJ; Naylor S
    Toxicol Lett; 2018 Sep; 294():193-204. PubMed ID: 29800716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?
    Mayeno AN; Belongia EA; Lin F; Lundy SK; Gleich GJ
    Mayo Clin Proc; 1992 Dec; 67(12):1134-9. PubMed ID: 1469924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,1'-Ethylidenebis[tryptophan] induces pathologic alterations in muscle similar to those observed in the eosinophilia-myalgia syndrome.
    Emslie-Smith AM; Mayeno AN; Nakano S; Gleich GJ; Engel AG
    Neurology; 1994 Dec; 44(12):2390-2. PubMed ID: 7991132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-tryptophan contaminant 'peak E' induces the release of IL-5 and IL-10 by peripheral blood mononuclear cells from patients with functional somatic syndromes.
    Barth H; Klein R; Berg PA
    Clin Exp Immunol; 2001 Nov; 126(2):187-92. PubMed ID: 11703359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and distribution in the rat of peak E substance, a constituent in L-tryptophan product implicated in eosinophilia-myalgia syndrome.
    Adachi J; Naito T; Ueno Y; Ogawa Y; Ninomiya I; Tatsuno Y
    Arch Toxicol; 1993; 67(4):284-9. PubMed ID: 8517785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of L-tryptophan for the etiology of eosinophilia-myalgia syndrome.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1990 Aug; 39(34):589-91. PubMed ID: 2166897
    [No Abstract]   [Full Text] [Related]  

  • 14. On-line HPLC-tandem mass spectrometry structural characterization of case-associated contaminants of L-tryptophan implicated with the onset of eosinophilia myalgia syndrome.
    Williamson BL; Johnson KL; Tomlinson AJ; Gleich GJ; Naylor S
    Toxicol Lett; 1998 Oct; 99(2):139-50. PubMed ID: 9817085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ["Eosinophilia-myalgia" syndrome due to L-tryptophan containing products. Cooperative evaluation of French Regional Centers of Pharmacovigilance. Analysis of 24 cases].
    Castot A; Bidault I; Bournerias I; Carlier P; Efthymiou ML
    Therapie; 1991; 46(5):355-65. PubMed ID: 1754978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From the Centers for Disease Control. Analysis of L-tryptophan for the etiology of eosinophilia-myalgia syndrome.
    JAMA; 1990 Oct; 264(13):1656. PubMed ID: 2169007
    [No Abstract]   [Full Text] [Related]  

  • 17. Analytical characterization of peptide contaminants of L-tryptophan.
    Barnhart ER; Maggio VL; Alexander LR; Reilly MC; Gelbaum LT; Turner WE; Hine TK; Needham LL
    Arch Environ Contam Toxicol; 1996 Jan; 30(1):142-8. PubMed ID: 8579384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological and immunological effects of ingesting L-tryptophan and 1,1'-ethylidenebis (L-tryptophan) in Lewis rats.
    Love LA; Rader JI; Crofford LJ; Raybourne RB; Principato MA; Page SW; Trucksess MW; Smith MJ; Dugan EM; Turner ML
    J Clin Invest; 1993 Mar; 91(3):804-11. PubMed ID: 8450062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer.
    Slutsker L; Hoesly FC; Miller L; Williams LP; Watson JC; Fleming DW
    JAMA; 1990 Jul; 264(2):213-7. PubMed ID: 2355442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EBT, a tryptophan contaminant associated with eosinophilia myalgia syndrome, is incorporated into proteins during translation as an amino acid analog.
    Buss WC; Stepanek J; Bankhurst AD; Mayeno AN; Pastuszyn A; Peabody D
    Autoimmunity; 1996; 25(1):33-45. PubMed ID: 9161698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.